DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes.
about
Novel treatment strategies in triple-negative breast cancer: specific role of poly(adenosine diphosphate-ribose) polymerase inhibitionIntegrating Multi-omics Data to Dissect Mechanisms of DNA repair Dysregulation in Breast CancerPatterns of cell cycle checkpoint deregulation associated with intrinsic molecular subtypes of human breast cancer cells.RECQ helicase RECQL4 participates in non-homologous end joining and interacts with the Ku complexStructural insights into 5' flap DNA unwinding and incision by the human FAN1 dimer.DNA repair gene polymorphisms and clinical outcome of patients with primary small cell carcinoma of the esophagus.Human DNA polymerase θ grasps the primer terminus to mediate DNA repairBRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer.Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells.A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients.Meta-Analyses of Microarray Datasets Identifies ANO1 and FADD as Prognostic Markers of Head and Neck CancerGene expression in "young adult type" breast cancer: a retrospective analysis.Estrogen Receptor Expression Is Associated with DNA Repair Capacity in Breast Cancer.Expression of DNA Damage Response Molecules PARP1, γH2AX, BRCA1, and BRCA2 Predicts Poor Survival of Breast Carcinoma Patients.Individual and Combined Expression of DNA Damage Response Molecules PARP1, γH2AX, BRCA1, and BRCA2 Predict Shorter Survival of Soft Tissue Sarcoma Patients.Systematic evaluation of underlying defects in DNA repair as an approach to case-only assessment of familial prostate cancerIntegrated MicroRNA-mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer.Targeting the microRNA-regulating DNA damage/repair pathways in cancer.Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes.Purine 5',8-cyclo-2'-deoxynucleoside lesions: formation by radical stress and repair in human breast epithelial cancer cells.Differential Potential of Pharmacological PARP Inhibitors for Inhibiting Cell Proliferation and Inducing Apoptosis in Human Breast Cancer Cells.Deciphering and Targeting Oncogenic Mutations and Pathways in Breast Cancer.TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers.Genomic Integration of High-Risk HPV Alters Gene Expression in Oropharyngeal Squamous Cell Carcinoma.Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatin.Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones.Bortezomib-induced miRNAs direct epigenetic silencing of locus genes and trigger apoptosis in leukemia.Base excision repair proteins couple activation-induced cytidine deaminase and endonuclease G during replication stress-induced MLL destabilization.An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypes.Kaempferol induces DNA damage and inhibits DNA repair associated protein expressions in human promyelocytic leukemia HL-60 cells.BUB1 mRNA is significantly co-expressed with AURKA and AURKB mRNA in advanced-stage ovarian serous carcinoma.A new risk score based on twelve hepatocellular carcinoma-specific gene expression can predict the patients' prognosis
P2860
Q26851765-A2085B26-8185-485B-B227-700CDBF015C9Q31132980-9807D10C-A741-4499-8043-0F4438D71894Q33731365-F2B8D340-56AB-489E-9E65-2BDE68EC0C8CQ34425537-DD9AA2F9-7FC2-4035-80B1-3A81B7E63079Q34453444-B454A1A4-AB22-4780-A95B-571BFCEBBD8CQ35221075-290B7BDC-D896-4525-A261-A0406654205BQ35269686-4ADFB748-FF0C-44AB-B0C1-2E3ABC3378DDQ35674192-648B7412-5A39-46AD-A965-F13DEB9BE958Q35820816-B4AA4DDC-1255-4212-A76E-9130610A0DAEQ35870483-592E897C-FC71-45D0-AF1B-B044E884156AQ35903521-1F366AC1-C15B-47A5-B7D1-889436FFF2E4Q35955416-465652F2-3C39-4687-98D9-AB44A01BA336Q35975638-D2684C3B-293F-42B2-8406-9B44B45CE93DQ36038008-FDE59E73-BF6C-43D9-AE44-3B5CF904E62EQ36137287-0E0A0468-CA27-49E3-A43D-ABCEE386C9D0Q36545434-25D8491F-2817-468B-9D84-36907426AC4FQ37631676-0AB62031-D434-4041-9AF2-2A507B268180Q38246220-3B8ED821-A139-4C9A-AEFC-762FF81E229DQ38547141-284DE8AB-99BE-46AE-BDF8-F79A010D7401Q38809426-5E928395-69F2-4B49-9075-79044EB5C8B7Q38874006-A17E04AE-9606-4AC6-8B24-0946CD613691Q38888022-5C2E37ED-2457-419A-94D0-872224CE3D05Q39030842-2108B133-E9FD-4E74-891C-9FF70C68DB16Q40611651-23A5E866-26E1-4A0E-833D-0F809A34BFC4Q42292342-66E5BF45-9EC2-48DE-89FF-0DC1EC97AF93Q42330187-D27E2F59-28AC-4C79-8381-B4B3700EEAADQ47421833-6319C09B-3B0F-464D-8720-CA7B496E74A8Q48261554-962583F4-F445-4FF1-AD88-CCD84DCFCF15Q52646057-4AEAE044-F03C-42C9-B9B9-7CE74A4448B6Q53222282-93B5D247-ABA5-486B-A951-695BC095325DQ54212025-26A1E126-B4CB-4C86-8B69-B409EE26CFACQ58703042-BB4A79C4-0A54-41F3-A5D7-377A9873CC95
P2860
DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
DNA repair gene patterns as pr ...... ecular breast cancer subtypes.
@en
DNA repair gene patterns as pr ...... ecular breast cancer subtypes.
@nl
type
label
DNA repair gene patterns as pr ...... ecular breast cancer subtypes.
@en
DNA repair gene patterns as pr ...... ecular breast cancer subtypes.
@nl
prefLabel
DNA repair gene patterns as pr ...... ecular breast cancer subtypes.
@en
DNA repair gene patterns as pr ...... ecular breast cancer subtypes.
@nl
P2093
P2860
P50
P1433
P1476
DNA repair gene patterns as pr ...... lecular breast cancer subtypes
@en
P2093
Gabriel N Hortobágyi
Giampaolo Bianchini
Giulia Bottai
Lajos Pusztai
Martha Stampfer
Naoki Hayashi
Nicholas C Turner
Takayuki Iwamoto
W Fraser Symmans
P2860
P304
P356
10.1634/THEONCOLOGIST.2013-0163
P577
2013-09-26T00:00:00Z